Superfluid Dx
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $8.2M
Investors
- 5
About Superfluid Dx
a.a. Superfluid Dx operates as a health tech company that focuses on developing precise and clinically valuable diagnostic tests through advancements in molecular biology, bioinformatics, and drug development. The company harnesses cell-free mRNA (cf-mRNA) to develop diagnostics. In December 2023, Superfluid Dx, Inc. The company provides a platform technology using cell-free mRNA (cf-mRNA) for early detection and management of neurodegenerative diseases, including Alzheimer's. The platform’s minimally invasive approach eliminates the need for invasive procedures like spinal taps and inaccurate brain scans. Superfluid's technology facilitates ongoing monitoring and guides therapy decisions by repeating assessments of a patient's disease state over time.
Who invested in Superfluid Dx
5 investors across 2 rounds
See all investors in Superfluid Dx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Superfluid Dx
Who invested in Superfluid Dx?
Superfluid Dx has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Superfluid Dx raised?
Superfluid Dx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Superfluid Dx last raise money?
Superfluid Dx's most recent round on record is a Series A, in Dec 2023.
What does Superfluid Dx do?
Superfluid Dx is a biotechnology company.
Where is Superfluid Dx headquartered?
Superfluid Dx is headquartered in South San Francisco, US.
Which VCs invest in companies like Superfluid Dx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Superfluid Dx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Superfluid Dx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.